Product Description
Tafazzin Peptide | 46-466P | ProSci
Short Description: Tafazzin Peptide
Species: Human
Location: Tafazzin peptide corresponds to 12 amino acids of Tafazzin.
Tested Application: Bl
Application: Tafazzin Peptide is used for blocking the activity of Tafazzin antibody (catalog number 46-466). The Tafazzin antibody ships at 0.5 mg/mL and the Tafazzin Peptide ships as a 100 ug pellet. When peptide is reconstituted in 200 uL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
Physical State: Lyophilized
Buffer: Tafazzin peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL.
Concentration: N/A
Storage: Store at -20˚C. When reconstituted minimize freezing and thawing.
NCBI Official Symbol: TAZ
Alternate Names: EFE, BTHS, EFE2, G4.5, Taz1, CMD3A, LVNCX, Tafazzin,
NCBI Gene ID: 6901
User Note: N/A
NCBI Official Name: Tafazzin
Background: N/A
Disclaimer: This product is for research use only.